SCHEMBL24933809

SCHEMBL24933809

Cc1cc(C)nc(COc2ccc(-c3cc(C(N)=O)c(=O)[nH]c3C(F)(F)F)cc2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 6/20 0.38
HSD17B2 P37059 6/20 0.38
PPARD Q03181 2/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
MAPT P10636 2/20 0.35
BLM P54132 2/20 0.35
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35
PARP1 P09874 3/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933706 0.90 PARP10 (0.39) HSD17B1HSD17B2PPARDCDK5CDK5R1
SCHEMBL24933369 0.88 HSD17B1 (0.38) HSD17B1HSD17B2PPARDCDK5CDK5R1
SCHEMBL30240787 0.88 HSD17B1 (0.38) HSD17B1HSD17B2PPARDCDK5CDK5R1
SCHEMBL24933222 0.87 PRKAB2 (0.44) HSD17B1HSD17B2CDK5CDK5R1PARP1
SCHEMBL24933881 0.86 HSD17B1 (0.38) HSD17B1HSD17B2PPARDCDK5CDK5R1
SCHEMBL24933693 0.83 PPARD (0.44) HSD17B1HSD17B2PPARD
SCHEMBL24933690 0.82 BTK (0.44) HSD17B1HSD17B2CDK5CDK5R1SCN9A
SCHEMBL24933256 0.82 PDK2 (0.43) HSD17B1HSD17B2PARP1BRD4BRD1
SCHEMBL24933637 0.82 MAOB (0.44) MAPTBLMPOLBPARP1HDAC3
SCHEMBL30240745 0.82 HSD17B1 (0.40) HSD17B1HSD17B2CDK5CDK5R1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN claimed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO claimed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed